Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Thirty years ago, the merger of Ciba-Geigy and Sandoz brought together two of Switzerland’s most storied companies and…
How Novartis R&D is advancing the next breakthrough innovations
Novartis is moving earlier, thinking differently, and making deliberate scientific choices to tackle some of medicine’s most complex…
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Thirty years ago today, the merger of Ciba-Geigy and Sandoz brought together two of Switzerland’s most storied companies…
The Future of Autoimmune Disease: A Q&A You Need to Read
We sat down with Christy Siegel, SVP and Therapeutic Area Head, Immunology, Novartis US, to explore how the…
A Conversation Women Wish They’d Had: Understanding the Risk of Breast Cancer Coming Back
For many women, the end of breast cancer treatment is described as a turning point, bringing mixed emotions…
The Novartis Next Generation Cancer Care Survey: A New Conversation about Care
People living with cancer today are navigating two realities at once: a moment of extraordinary scientific progress, and…
ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture
Legend Biotech presented preliminary results from its ongoing Phase I/II trial of LB2102 (NCT05680922), an armoured delta-like ligand…
The Novartis Next Generation Cancer Care Survey: A New Conversation about Care
People living with cancer today are navigating two realities at once: a moment of extraordinary scientific progress, and…
Stroke Awareness Month: What You Should Know About Your Stroke Risk
If you believe someone is exhibiting the signs and symptoms of a stroke, remember this acronym: FAST5. F…
How This Former Army Officer Helps Deliver Cancer Treatments to Patients, Through Hurricanes and Beyond
What was it about radioligand therapy that interested you in particular? I had made a connection at another…
Supercharged Ireland | Business Powered By AI
At Novartis Ireland, we are incredibly proud of the AI leadership, talent, and innovation happening in Dublin —…
New long term social impact and sustainability targets
Anchored in our Code of Ethics, Novartis Ethics, Risk and Compliance (ERC) Program sets clear principles and expectations…